Mobile Support for Lung Cancer Surgery Patients

Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform

Recruiting N/A Interventional Study
Lung Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
216 (estimated)
Sponsor
Shanghai Chest Hospital · Other
Who this trial is looking for

This trial is looking for patients who have had surgery for lung cancer. Participants will use a mobile platform to share their recovery experiences and help improve care.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with Stage I-III lung cancer.
  • I have had lung cancer surgery.
  • I own and use a smartphone.
  • I can use WeChat.
  • I want to participate in this study.
  • I can sign an informed consent form.

You may not be able to join if

  • I have received non-surgical treatment like chemotherapy for lung cancer.
  • I have serious health problems that make surgery risky.
  • My surgery needs to be changed to an emergency procedure.
  • I want to withdraw from the study for personal reasons.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study focuses on the significant impact of lung cancer in China, highlighted by its high incidence and mortality rates, influenced by factors like aging populations, smoking, and environmental issues. It emphasizes the importance of understanding the duration, severity, and factors affecting post-surgery symptoms like pain and coughing in patients. The research underlines the value of patient…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Diagnosed with Stage I-III lung cancer and surgically resected at our centre. 2. Owns and uses a smartphone and can use WeChat. 3. Volunteer to participate in this study and sign an informed consent form. Exclusion Criteria: 1. Received any non-surgical anti-tumour therapy …
Contacts

Xinghua Cheng, MD

+8617701681215

chengxinghua_001@163.com

CONTACT

Xinghua Cheng

+8617701681215

chengxinghua_001@163.com

CONTACT